[
    [
        {
            "time": "2020-06-05",
            "original_text": "每日医药简讯：国家医保局将拟医药价格建信用评价制度、全球疫苗峰会筹资超74亿美元、健帆生物控股股东减持",
            "features": {
                "keywords": [
                    "国家医保局",
                    "医药价格",
                    "信用评价制度",
                    "全球疫苗峰会",
                    "筹资",
                    "健帆生物",
                    "控股股东",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "每日医药简讯：国家医保局将拟医药价格建信用评价制度、全球疫苗峰会筹资超74亿美元、健帆生物控股股东减持",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "健帆生物：控股股东、实际控制人董凡减持公司股份1919.45万股 减持股份数量",
            "features": {
                "keywords": [
                    "健帆生物",
                    "控股股东",
                    "实际控制人",
                    "董凡",
                    "减持",
                    "股份数量"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：控股股东、实际控制人董凡减持公司股份1919.45万股 减持股份数量",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "健帆生物：6月初3天减持1.45% 实控人减持计划实施完毕 拟减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "实控人",
                    "减持计划",
                    "实施完毕",
                    "拟减持股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：6月初3天减持1.45% 实控人减持计划实施完毕 拟减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "健帆生物(300529.SZ)：控股股东减持完毕 累计减持3.26%股份 减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "控股股东",
                    "减持完毕",
                    "累计减持",
                    "股份"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：控股股东减持完毕 累计减持3.26%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "健帆生物：控股股东、实际控制人减持计划实施完毕 减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "控股股东",
                    "实际控制人",
                    "减持计划",
                    "实施完毕",
                    "减持股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：控股股东、实际控制人减持计划实施完毕 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "午间公告2020年6月5日星期五",
            "features": {
                "keywords": [],
                "sentiment_score": 0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "午间公告2020年6月5日星期五",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "A股早报2020年6月5日星期五",
            "features": {
                "keywords": [],
                "sentiment_score": 0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股早报2020年6月5日星期五",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-05",
            "original_text": "5月重要股东增减持：医药生物减持频现 智飞生物、健帆生物居前 减持股份",
            "features": {
                "keywords": [
                    "重要股东",
                    "增减持",
                    "医药生物",
                    "减持频现",
                    "智飞生物",
                    "健帆生物",
                    "减持股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "5月重要股东增减持：医药生物减持频现 智飞生物、健帆生物居前 减持股份",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]